Read Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial Reader
Add Comment
double-blind,
multicenter trial,
placebo-controlled,
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized
Edit
Download Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, ...
Read More
